American Express
AXP
$304.55
+0.17%
American Express is a global financial institution operating in roughly 130 countries, providing consumers and businesses with charge and credit card payment products while also running a highly profitable closed-loop merchant payment network across four reporting segments: US Consumer Services, US Commercial Services, International Card Services, and Global Merchant and Network Services. Unlike pure-play card networks or traditional banks, Amex is a vertically integrated, premium-brand franchise that both issues cards and acquires merchants, capturing economics on both sides of the transaction and monetizing an affluent, high-spending cardmember base through annual fees, interest income, and discount revenue. The current investor narrative centers on whether the premium consumer remains resilient amid a slowing macro backdrop, with recent headlines highlighting 15% growth in card-fee revenue and management raising full-year revenue guidance even as the stock sold off on a modest top-line miss. Debate now hinges on whether the market is underrating Amex's long-term growth runway — bulls point to the fee-based, credit-light revenue mix and a compelling multiple, while bears flag decelerating billings, rising credit normalization, and intensifying competition from buy-now-pay-later players and fintech challengers.…
AXP
American Express
$304.55
Related headlines
Investment Opinion: Should I buy AXP Today?
Based on the synthesis of technical, fundamental, and analyst data, the recommendation is a Hold with a bias toward accumulation on further weakness. The core thesis is that American Express's premium franchise, strong ROE of 32.36%, and forward PE of 15.01x offer value, but near-term headwinds and technical breakdown warrant caution. The analyst consensus rating of 'buy' with an average target of $375.83 (24.1% upside) supports a constructive view, but the stock's 18.77% YTD decline and proximity to 52-week lows suggest the market is pricing in significant risks.
Supporting evidence includes: 1) Revenue growth of 8.34% YoY in Q2 2026, with net income of $3.11 billion and a net margin of 14.40%; 2) Free cash flow of $15.052 billion TTM, easily covering dividends and buybacks; 3) A forward PE of 15.01x, which is below the trailing PE of 24.01x and implies expected earnings growth; 4) Analyst targets ranging from $320 to $450, with the average at $375.83, indicating substantial upside if execution improves. However, the PEG ratio of 2.46x suggests the stock is not cheap relative to growth, and the PB ratio of 7.68x is historically high.
The biggest risks that could invalidate the thesis are: 1) A recession leading to credit losses and reduced spending, which would pressure earnings; 2) Continued revenue deceleration below 8%, which could trigger further multiple compression; 3) Competitive threats from BNPL and fintech eroding market share. The rating would upgrade to Buy if the stock stabilizes above $320 and revenue growth accelerates above 10%, or downgrade to Sell if it breaks below $290 with deteriorating credit metrics. Relative to its history and peers, the stock appears fairly valued on a forward basis but overvalued on trailing metrics, suggesting a neutral stance until clearer growth signals emerge.
Sign up to view all
AXP 12-Month Price Forecast
The forward-looking view is neutral with a medium confidence level, balancing attractive valuation and analyst optimism against technical weakness and macro risks. The stock's forward PE of 15.01x suggests the market is pricing in significant earnings growth, but revenue deceleration and credit normalization pose challenges. Analyst targets imply substantial upside, yet the persistent downtrend and relative underperformance indicate deep skepticism. Key factors to monitor include Q3 earnings for signs of revenue reacceleration and credit quality trends. An upgrade to bullish would require a breakout above $340 and sustained revenue growth above 9%, while a downgrade to bearish would occur if the stock breaks below $290 with deteriorating credit metrics.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American Express's 12-month outlook, with a consensus price target around $372.20 and implied upside of +22.2% versus the current price.
Average Target
$372.20
0 analysts
Implied Upside
+22.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$320 - $450
Analyst target range
American Express is covered by 24 analysts with a consensus recommendation of "buy" and a recommendation mean of 2.17 (on a scale where lower is more bullish), reflecting a constructive but not uniformly enthusiastic stance. The average price target is $375.83, which implies approximately 24.1% upside from the current price of $302.78, a substantial gap that suggests analysts view the recent selloff as overdone relative to fundamental value. The consensus leans bullish, with the average target well above the current price and the recommendation mean sitting in buy territory, though the presence of neutral and sell ratings indicates the bullishness is not unanimous. The implied upside of +24.1% to the consensus target is notable given the stock's -8.38% 1-year and -18.77% YTD performance, implying analysts expect a meaningful re-rating or recovery. The target range spans from a low of $320.00 to a high of $450.00, a spread of $130 or roughly 41% of the low target, which signals meaningful dispersion in analyst views and elevated uncertainty about the company's trajectory. The high target of $450.00 implies roughly 48.6% upside and would require multiple expansion toward the upper end of Amex's historical PE band alongside accelerating revenue growth and sustained credit quality, while the low target of $320.00 implies just 5.7% upside and prices in margin compression, credit normalization, or a more challenging consumer environment. Institutional ratings show a mix of actions: JP Morgan upgraded to Overweight from Neutral on 2026-07-13, while BTIG maintained a Sell rating and UBS, Morgan Stanley, and Barclays stayed Neutral or Equal Weight, indicating that while some analysts see value, others remain cautious on valuation and growth durability. The wide target spread, combined with the recent downgrade-to-upgrade mix and the stock's sharp underperformance, suggests the market is in a period of price discovery where conviction is moderate and the risk of further volatility remains elevated.
Bulls vs Bears: AXP Investment Factors
The bear case currently has stronger evidence due to the stock's severe technical breakdown, with shares down 18.77% YTD and trading near 52-week lows, reflecting deep market skepticism. However, the bull case rests on compelling fundamentals: a forward PE of 15.01x, 8.34% revenue growth, and a 24.1% analyst upside, suggesting the selloff may be overdone. The most critical tension is whether the premium consumer remains resilient amid macro headwinds—if credit quality holds and fee revenue continues to grow, the stock could re-rate; if not, further downside is likely. The divergence between technical weakness and fundamental strength creates a high-stakes debate for investors.
Bullish
- Attractive Forward Valuation: The forward PE of 15.01x is significantly below the trailing PE of 24.01x, implying a 37% earnings growth expectation that may be overly pessimistic. With consensus EPS of $29.32, the stock trades at a discount to its historical average forward multiple, offering a compelling entry point if growth materializes.
- Strong Profitability and Returns: American Express generates a robust ROE of 32.36% and a net margin of 14.40% in Q2 2026, far exceeding typical banking peers. The gross margin expanded to 85.91% from 82.53% year-over-year, highlighting the high-margin, fee-based nature of its closed-loop network.
- Consistent Revenue Growth: Revenue grew 8.34% year-over-year to $21.595 billion in Q2 2026, with steady sequential increases over the past five quarters. This growth is broad-based across consumer and commercial segments, underscoring the resilience of the premium cardmember base.
- Analyst Consensus Upside: The average analyst target price of $375.83 implies 24.1% upside from the current price of $302.78, with a consensus recommendation of 'buy' (mean 2.17). This suggests that analysts view the recent selloff as overdone relative to fundamental value.
Bearish
- Severe Technical Downtrend: The stock is down 18.77% year-to-date and 8.38% over the past year, significantly underperforming the S&P 500's gains. It sits just 3.9% above its 52-week low of $290.97, with negative momentum accelerating (1-month change: -8.24%).
- Elevated Trailing Valuation: The trailing PE of 24.01x is near the upper end of its historical range (11.3x to 26.2x), and the PB ratio of 7.68x is at the high end of its historical band. This leaves little room for error if earnings growth disappoints.
- Decelerating Revenue Growth: Year-over-year revenue growth of 8.34% is healthy but moderating from prior double-digit rates. The Q2 2026 revenue of $21.595 billion missed some analyst expectations, triggering a 6.5% selloff on July 24, 2026.
- Rising Credit Normalization Risks: As a lender, American Express faces potential credit deterioration in a slowing economy. The debt-to-equity ratio of 1.73 and current ratio of 0.284 reflect financial leverage, and any uptick in cardmember delinquencies could pressure earnings.
AXP Technical Analysis
American Express is in a clear medium-term downtrend, with the stock down 8.38% over the past year and 18.77% year-to-date, a stark divergence from the S&P 500's +15.01% 1-year and +12.86% YTD gains. At $302.78, the shares sit just 3.9% above their 52-week low of $290.97 and roughly 21.9% below the 52-week high of $387.49, placing the stock at approximately 22% of its 52-week range — deep in the lower quartile, which signals persistent distribution rather than a healthy pullback and raises the risk of a falling-knife dynamic if support fails. The 6-month change of +0.87% versus the 1-year decline of -8.38% suggests the damage has been concentrated in recent months rather than spread evenly across the year. Short-term momentum is decisively negative and worsening: the 1-month change of -8.24% and 3-month change of -13.97% show acceleration to the downside, with the 3-month figure worse than the 1-year figure, indicating the selloff has intensified rather than stabilized. Relative strength is deeply negative across every window — -8.83% over 1 month, -17.31% over 3 months, -23.39% over 1 year, and -31.63% YTD — confirming Amex is a significant laggard versus the market, and the 1-month relative weakness of -8.83% against SPY's +0.59% shows no sign of mean reversion yet. The stock's decline from a July peak near $361.57 to the current $302.78 represents a roughly 16% drawdown in under three months, underscoring the severity of the momentum breakdown. Key technical levels are well defined: immediate support rests at the 52-week low of $290.97, and a decisive breakdown below that level would likely open the door to further downside and confirm a full trend reversal, while resistance sits at the 52-week high of $387.49, with intermediate resistance around the $330-$340 zone where the stock repeatedly stalled in August and September. The beta of 1.048 indicates the stock moves roughly in line with the market — only about 5% more volatile than SPY — so the underperformance is driven by stock-specific factors rather than leverage to market swings, meaning position sizing should account for idiosyncratic risk. The maximum drawdown of -24.06% over the period reinforces that this is a name capable of meaningful capital impairment, and the short ratio of 4.51 suggests bears have built a meaningful but not extreme short position that could fuel a squeeze on any positive catalyst.
Beta
1.08
1.08x market volatility
Max Drawdown
-24.1%
Largest decline past year
52-Week Range
$291-$387
Price range past year
Annual Return
-8.3%
Cumulative gain past year
| Period | AXP Return | S&P 500 |
|---|---|---|
| 1m | -6.6% | +1.2% |
| 3m | -9.5% | +4.5% |
| 6m | -4.2% | +14.6% |
| 1y | -8.3% | +16.0% |
| ytd | -18.3% | +14.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXP Fundamental Analysis
American Express's revenue trajectory remains solidly positive, with Q2 2026 revenue of $21.595 billion representing 8.34% year-over-year growth versus Q2 2025's $19.933 billion, and the multi-quarter trend shows steady expansion from $18.933 billion in Q1 2025 through $20.557 billion in Q3 2025, $21.041 billion in Q4 2025, $20.880 billion in Q1 2026, and $21.595 billion in Q2 2026. Sequentially, revenue rose 3.4% from Q1 2026 to Q2 2026, and the year-over-year growth rate of 8.34% is healthy though moderating from the double-digit pace the company posted in prior cycles, consistent with a maturing but still-growing franchise. Segment data shows Global Consumer Services Group is the largest contributor at $9.524 billion, followed by Global Commercial Services at $4.503 billion, International Card Services at $3.619 billion, and Global Merchant and Network Services at $2.096 billion, with the consumer and commercial segments together accounting for roughly 65% of segment revenue and driving the bulk of growth. The key takeaway is that Amex's growth is broad-based and fee-supported rather than dependent on a single line, which underpins the durability of the investment case even as headline growth decelerates. Profitability is robust and improving: Q2 2026 net income was $3.11 billion on a net margin of 14.40%, up from $2.885 billion and a 14.47% margin in Q2 2025, while gross margin expanded to 85.91% from 82.53% a year earlier and operating margin reached 43.24% versus 17.81% in the prior-year quarter. The gross margin of 83.23% and operating margin of 17.14% on a trailing basis reflect the high-margin, fee-heavy nature of the closed-loop network, and the Q2 operating margin of 43.24% — though flattered by interest income and other line items — underscores the operating leverage inherent in the model. Net income has grown sequentially from $2.462 billion in Q4 2025 to $2.971 billion in Q1 2026 to $3.11 billion in Q2 2026, and the net margin has held in the 14-14.4% range over the last three quarters, indicating stable and defensible profitability. The balance sheet and cash flow profile are solid but carry financial-sector leverage: debt-to-equity stands at 1.73, ROE is a strong 32.36%, and ROA is a modest 3.79%, reflecting the capital-intensive nature of a lending and payments business. Free cash flow on a trailing basis is $15.052 billion, with Q2 2026 free cash flow of $4.473 billion and operating cash flow of $5.371 billion, comfortably covering $665 million in dividends and $2.304 billion in buybacks during the quarter. The current ratio of 0.284 appears low but is typical for a financial institution where current liabilities include large short-term funding obligations; the company holds $45.243 billion in cash at period end, and the dividend yield of 0.88% with a payout ratio of just 20.96% leaves ample room for continued capital return and reinvestment.
Quarterly Revenue
$21.6B
2026-06
Revenue YoY Growth
+8.3%
YoY Comparison
Gross Margin
85.9%
Latest Quarter
Free Cash Flow
$15.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXP Overvalued?
Because American Express is solidly profitable with positive net income of $3.11 billion in Q2 2026, the PE ratio is the appropriate primary valuation metric. The stock trades at a trailing PE of 24.01x and a forward PE of 15.01x, and the wide gap between these two figures — a roughly 37% compression — implies the market expects meaningful earnings growth ahead, consistent with consensus EPS estimates of $29.32 for the forward period versus the current trailing EPS base. The forward PE of 15.01x is notably low in absolute terms for a premium financial franchise, suggesting either that the market is pricing in significant earnings acceleration or that the stock has been de-rated to a level that may not reflect its earnings power. On a peer comparison basis, the trailing PE of 24.01x sits at a premium to the broader financial services sector, while the forward PE of 15.01x is closer to or below sector averages depending on the peer set, and the PB ratio of 7.68x is elevated relative to traditional banks but justified by Amex's 32.36% ROE, which is far above the low-teens ROE typical of large-cap banks. The PS ratio of 3.20x and EV/EBITDA of 17.16x are reasonable for a high-margin, fee-driven network business, and the PEG ratio of 2.46x suggests the stock is not cheap relative to its growth rate, though the forward earnings multiple tells a more constructive story. Historically, Amex's PE ratio has ranged from roughly 11.3x (Q3 2023) to 26.2x (Q4 2025), and the current trailing PE of 24.01x sits near the upper end of that band, while the forward PE of 15.01x is closer to the middle-to-lower end, implying the market is pricing in a sharp earnings rebound. The PB ratio of 7.68x is near the high end of its historical range (which has spanned roughly 4.0x to 7.6x over the past several years), suggesting the market continues to award Amex a premium book-value multiple despite the price decline, reflecting confidence in its franchise quality and returns. The tension between the elevated trailing multiples and the depressed forward multiple captures the core valuation debate: if earnings materialize as consensus expects, the stock is inexpensive; if growth disappoints, the trailing premium is vulnerable to further compression.
PE
24.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 13x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are centered on American Express's leveraged balance sheet and potential credit deterioration. The debt-to-equity ratio of 1.73 and current ratio of 0.284 indicate significant reliance on short-term funding, typical for financial institutions but vulnerable to liquidity crunches. While net income grew to $3.11 billion in Q2 2026 with a 14.40% net margin, any increase in credit losses or funding costs could compress margins, especially with interest expense at $1.958 billion in Q2. Additionally, revenue concentration in US Consumer Services ($9.524 billion) and US Commercial Services ($4.503 billion) exposes the company to a slowdown in domestic spending.
Market and competitive risks include valuation compression and intensifying competition. The trailing PE of 24.01x is near historical highs, and the PB ratio of 7.68x is elevated, leaving the stock vulnerable to multiple contraction if growth slows. With a beta of 1.048, Amex is slightly more volatile than the market, but its 23.39% relative underperformance over the past year is driven by idiosyncratic factors like the Q2 revenue miss. Competition from BNPL firms such as Affirm, which reported strong GMV growth, and fintech challengers could erode Amex's premium cardmember base and fee revenue.
In a worst-case scenario, a recession leading to rising unemployment and credit defaults would hit Amex's lending book hard, while simultaneously reducing consumer spending. This could trigger a breakdown below the 52-week low of $290.97, with the stock potentially falling to the analyst low target of $320.00 (which is actually above current price, but in a severe scenario, it could drop to $250 or lower based on historical drawdowns). The maximum drawdown of -24.06% over the period suggests that from the current price of $302.78, a similar drawdown would take the stock to around $230, representing a 24% loss. If credit conditions worsen, the stock could test the 2023 lows around $220, implying a 27% downside from current levels.
FAQ
The key risks for AXP can be ranked by severity: 1) Credit risk: as a lender, Amex faces potential losses if the economy weakens; the debt-to-equity ratio of 1.73 and current ratio of 0.284 highlight financial leverage, and any rise in delinquencies could hit earnings. 2) Competitive risk: BNPL players like Affirm are growing rapidly, threatening Amex's premium market share and fee revenue. 3) Macro risk: with a beta of 1.048, the stock is sensitive to market swings, and a recession could reduce consumer spending and increase credit losses. 4) Valuation risk: the trailing PE of 24.01x is near historical highs, leaving little room for error; a growth slowdown could trigger multiple contraction. These risks are significant, but Amex's strong brand and high margins provide some cushion.
The 12-month forecast for AXP includes three scenarios: bull case (25% probability) with a target range of $400-$450, driven by revenue reacceleration and multiple expansion; base case (55% probability) with a target range of $340-$380, assuming 7-9% revenue growth and stable margins; and bear case (20% probability) with a target range of $250-$290, triggered by a recession and credit deterioration. The base case is most likely, aligning with the analyst average target of $375.83 and implying a 24.1% upside from the current price. The key assumption is that the premium consumer remains resilient and credit quality holds, allowing earnings to meet consensus. However, if revenue growth decelerates below 5% or credit losses rise, the bear case could materialize.
AXP's valuation is nuanced: on a trailing basis, the PE of 24.01x and PB of 7.68x are near the high end of historical ranges, suggesting overvaluation relative to the past. However, the forward PE of 15.01x is more reasonable and implies the market expects significant earnings growth, with consensus EPS of $29.32. Compared to peers, the PB ratio is elevated but justified by a 32.36% ROE, far above the low-teens ROE of large banks. The PS ratio of 3.20x and EV/EBITDA of 17.16x are in line with high-margin financial networks. Overall, the stock appears fairly valued on a forward basis but could be undervalued if earnings materialize as expected. The market is pricing in a growth rebound, so any disappointment could lead to further multiple compression.
From a risk/reward perspective, AXP presents a mixed picture. The stock trades at a forward PE of 15.01x, which is attractive for a company with a 32.36% ROE and 8.34% revenue growth, and analysts see 24.1% upside to their average target of $375.83. However, the technical downtrend is severe, with the stock down 18.77% YTD and just 3.9% above its 52-week low, indicating significant near-term risk. The biggest downside risk is a recession that could lead to credit losses and push the stock below $290. For long-term investors with a 2-3 year horizon, the current price may offer a good entry point, but short-term traders should wait for stabilization above $320. It is a good buy for those who believe in the premium consumer's resilience and can tolerate volatility.
AXP is more suitable for long-term investment than short-term trading. The company is a mature, profitable franchise with a 32.36% ROE, consistent free cash flow, and a dividend yield of 0.88%, making it a candidate for a long-term core holding in a financial sector allocation. However, the stock's beta of 1.048 and recent volatility (max drawdown of -24.06%) mean short-term trading carries high risk, especially with the current downtrend. Earnings visibility is moderate, with quarterly fluctuations, and the stock is sensitive to macro news. A suggested minimum holding period is 2-3 years to allow for recovery and compounding of earnings growth. Short-term traders might find opportunities around earnings announcements, but the overall profile favors patient investors.